“Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial”, J of Skin, vol. 5, no. 1, p. s5, Jan. 2021, doi: 10.25251/skin.5.supp.5.